S1182-118

Introduced

To amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes.

118th Congress Introduced Apr 18, 2023

Summary

What This Bill Does

The bill requires short title This Act may be cited as the 340B Reporting and Accountability Act and requires requirement to provide drug discounts to patients Section 340B(a)(5) of the Public Health Service Act (42 U.S.C. It relies on reporting requirements, definition changes, compliance mandates, and procurement rules. The main policy areas are Healthcare Consumers and Healthcare.

Who Benefits and How

Public beneficiaries or protected communities affected by the clause could face reduced risk and Patients and health care consumers affected by the bill could gain revenue opportunities.

Who Bears the Burden and How

Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Patients and health care consumers affected by the bill would take on compliance duties.

Key Provisions

  • Requires short title This Act may be cited as the 340B Reporting and Accountability Act.
  • Requires requirement to provide drug discounts to patients Section 340B(a)(5) of the Public Health Service Act (42 U.S.C.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill requires short title This Act may be cited as the 340B Reporting and Accountability Act and requires requirement to provide drug discounts to patients Section 340B(a)(5) of the Public Health Service Act (42 U.S.C.

Key Policy Areas

Healthcare Consumers, Healthcare

Primary Purpose

The bill requires short title This Act may be cited as the 340B Reporting and Accountability Act and requires requirement to provide drug discounts to patients Section 340B(a)(5) of the Public Health Service Act (42 U.S.C.

Policy Domains

Healthcare Consumers Healthcare

Whole bill

Identified Gains
  • Public beneficiaries or protected communities affected by the clause
  • Patients and health care consumers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Patients and health care consumers affected by the bill:
Public beneficiaries or protected communities affected by the clause: ,
Identified Costs
  • Federal, state, or local agencies responsible for implementing the clause
  • Patients and health care consumers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Patients and health care consumers affected by the bill:
Federal, state, or local agencies responsible for implementing the clause: ,

Legislative Progress

Introduced
Introduced Committee Passed
Apr 18, 2023

Mr. Kennedy introduced the following bill; which was read twice …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Consumers Healthcare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology